CPG
CHRS icon

Cornerstone Planning Group’s Coherus Oncology CHRS Stock Holding History

Cornerstone Planning Group’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-49
Closed -$54 – 1556
2025
Q1 		$54 Hold
49
– – ﹤0.01% 1522
2024
Q4 		$57 Hold
49
– – ﹤0.01% 1363
2024
Q3 		$36 Hold
49
– – ﹤0.01% 1275
2024
Q2 		$65 Hold
49
– – ﹤0.01% 1217
2024
Q1 		$112 Hold
49
– – ﹤0.01% 1041
2023
Q4 		$163 Hold
49
– – ﹤0.01% 874
2023
Q3 		$183 Buy
+49
New +$226 ﹤0.01% 1038

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Cornerstone Planning Group's CHRS Position: Q2 2025 in Review

Cornerstone Planning Group sold out of Coherus Oncology (CHRS) in Q2 2025, closing a stake of 49 shares — an estimated $54 sold.

Cornerstone Planning Group first reported a position in CHRS in Q3 2023 and held it in 7 quarters. The position peaked at $183 in Q3 2023. 112 funds tracked by Wall St. Rank hold CHRS as of Q2 2025.

  • Cornerstone Planning Group reported no remaining Coherus Oncology position as of Q2 2025 after selling out during the quarter.
  • Cornerstone Planning Group sold 49 Coherus Oncology shares in Q2 2025, an estimated $54.
  • Cornerstone Planning Group first reported a position in Coherus Oncology in Q3 2023 and held it in 7 quarters.
  • Cornerstone Planning Group's Coherus Oncology position peaked at $183 in Q3 2023.
  • 112 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2025.

Based on Cornerstone Planning Group's 13F filing for Q2 2025, filed 11 Aug 2025.